Scripps Tumorgraft Study

Scripps Translational Science Institute

Status: Completed

Conditions: Solid Tumor Malignancy or Hematologic Malignancy

Study type: Observational

Funder types: Other

Identifiers

NCT01726699

12-6011

Details and patient eligibility

About

Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.

Enrollment: 11 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 21 or over
• diagnosis of a solid tumor malignancy, either resectable or metastatic or a hematologic malignancy
• cognitively and emotionally able to give informed consent

Exclusion criteria

• Under age 21
• Not cognitively or emotionally able to give informed consent

Trial design

11 participants in 1 patient group

Cancer Diagnosis